Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a

Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a

BACKGROUND: Typhoid persists as a major cause of global morbidity. While several licensed vaccines to prevent typhoid are available, they are of only moderate efficacy and unsuitable for use in children less than two years of age. Development of new efficacious vaccines is complicated by the human h...

Full description

Bibliographic Details
Main Authors:	Darton, T, Jones, C, Blohmke, C, Waddington, C, Zhou, L, Peters, A, Haworth, K, Sie, R, Green, C, Jeppesen, C, Moore, M, Thompson, B, John, T, Kingsley, R, Yu, L, Voysey, M, Hindle, Z, Lockhart, S, Sztein, M, Dougan, G, Angus, B, Levine, M, Pollard, A
Format:	Journal article
Language:	English
Published:	Public Library of Science 2016

Similar Items

Live attenuated oral vaccine, age and anti-Vi antibody status at baseline significantly affect attack rate in a human Salmonella Typhi challenge model
by: Darton, T, et al.
Published: (2015)

Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.
by: McArthur, M, et al.
Published: (2015)

Oral wild-type Salmonella Typhi challenge induces activation of circulating monocytes and dendritic cells in individuals who develop typhoid disease
by: Toapanta, F, et al.
Published: (2015)

Importance of Salmonella Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model
by: Fresnay, S, et al.
Published: (2017)

Demonstration of primary and asymptomatic DNAaemia in participants challenged with Salmonella Typhi (Quailes strain) during the development of a human model of typhoid infection
by: Darton, T, et al.
Published: (2012)

Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans
by: Fresnay, S, et al.
Published: (2016)

A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children.
by: Tran, T, et al.
Published: (2010)

A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children.
by: Tran, T, et al.
Published: (2010)

Oral challenge with wild-type Salmonella Typhi induces distinct changes in B cell subsets in individuals who develop typhoid disease.
by: Toapanta, F, et al.
Published: (2016)

Typhoid epidemiology, diagnostics and the human challenge model.
by: Darton, T, et al.
Published: (2014)

Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in HumansSummary
by: Jayaum S. Booth, et al.
Published: (2017-11-01)

Induction of cell cycle and NK cell responses by live-attenuated oral vaccines against typhoid fever
by: Blohmke, CJ, et al.
Published: (2017)

A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children.
by: Tinh Hien Tran, et al.
Published: (2010-07-01)

Advancing the management and control of typhoid fever: A review of the historical role of human challenge studies
by: Waddington, C, et al.
Published: (2014)

The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK
by: Meiring, J, et al.
Published: (2017)

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever
by: Salerno-Gonçalves, R, et al.
Published: (2022)

Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.
by: Monica A McArthur, et al.
Published: (2015-05-01)

Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever
by: Christoph J. Blohmke, et al.
Published: (2017-10-01)

Typhoid in Africa and vaccine deployment
by: Gordon Dougan
Published: (2017-03-01)

Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type S. Typhi in humans
by: Booth, JS, et al.
Published: (2024)

Blood culture-PCR to optimise typhoid fever diagnosis after controlled human infection identifies frequent asymptomatic cases and evidence of primary bacteraemia.
by: Darton, T, et al.
Published: (2017)

Interferon-driven alterations of the host’s amino acid metabolism in the pathogenesis of typhoid fever
by: Blohmke, C, et al.
Published: (2016)

Application of a challenge model to assess the protective efficacy of oral typhoid vaccines in humans
by: Darton, T, et al.
Published: (2014)

Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies.
by: Waddington, C, et al.
Published: (2014)

The design and analysis of seroefficacy studies for typhoid conjugate vaccines
by: Liu, X, et al.
Published: (2019)

Attenuated Oral Typhoid Vaccine Ty21a Elicits Lamina Propria and Intra-Epithelial Lymphocyte Tissue-Resident Effector Memory CD8 T Responses in the Human Terminal Ileum
by: Jayaum S. Booth, et al.
Published: (2019-03-01)

Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans
by: Darton, T, et al.
Published: (2015)

Quantification of antibody secreting cell responses in a human challenge model of Salmonella Typhi infection
by: Jones, C, et al.
Published: (2012)

Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease.
by: Franklin R Toapanta, et al.
Published: (2016-06-01)

Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV)
by: Voysey, M, et al.
Published: (2018)

Understanding typhoid disease; a controlled human infection model of typhoid fever
by: Waddington, C, et al.
Published: (2014)

Molecular correlates of vaccine-induced protection against typhoid fever
by: Zhu, H, et al.
Published: (2023)

Association between S. Typhi-specific memory CD4+ and CD8+ T responses in the terminal ileum mucosa and in peripheral blood elicited by the live oral typhoid vaccine Ty21a in humans
by: Jayaum S. Booth, et al.
Published: (2019-06-01)

An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.
by: Waddington, C, et al.
Published: (2014)

Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization.
by: Monica A McArthur, et al.
Published: (2012-01-01)

Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products
by: M. V. Abramtseva, et al.
Published: (2021-07-01)

Challenge of humans with wild-type Salmonella enterica serovar Typhi elicits changes in the activation and homing characteristics of mucosal-associated invariant T cells.
by: Salerno-Goncalves, R, et al.
Published: (2017)

Modeling the potential impact of typhoid conjugate vaccines
by: V.E. Pitzer, et al.
Published: (2014-04-01)

Variations in attack rate in a single-blind, dose escalation challenge study of Salmonella Typhi in healthy adult volunteers
by: Waddington, C, et al.
Published: (2012)

Typhoid conjugate vaccines: a step towards typhoid control
by: Shakya, M, et al.
Published: (2024)